BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37178235)

  • 1. Impact of liver volumetric regeneration on survival outcomes in patients with hepatocellular carcinoma after major hepatectomy.
    Nam NH; Yoh T; Hori Y; Morino K; Nishino H; Nishio T; Koyama Y; Ogiso S; Nagai K; Fukumitsu K; Uchida Y; Ito T; Ishii T; Seo S; Hata K; Taura K; Hatano E
    Langenbecks Arch Surg; 2023 May; 408(1):193. PubMed ID: 37178235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overall Tumor Burden Dictates Outcomes for Patients Undergoing Resection of Multinodular Hepatocellular Carcinoma Beyond the Milan Criteria.
    Tsilimigras DI; Mehta R; Paredes AZ; Moris D; Sahara K; Bagante F; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Grigorie R; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Spolverato G; Umberto C; Pawlik TM
    Ann Surg; 2020 Oct; 272(4):574-581. PubMed ID: 32932309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Onodera's prognostic nutritional index is a strong prognostic indicator for patients with hepatocellular carcinoma after initial hepatectomy, especially patients with preserved liver function.
    Tanemura A; Mizuno S; Hayasaki A; Gyoten K; Fujii T; Iizawa Y; Kato H; Murata Y; Kuriyama N; Kishiwada M; Sakurai H; Isaji S
    BMC Surg; 2020 Oct; 20(1):261. PubMed ID: 33129309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor size may influence the prognosis of solitary hepatocellular carcinoma patients with cirrhosis and without macrovascular invasion after hepatectomy.
    Liang BY; Gu J; Xiong M; Zhang EL; Zhang ZY; Chen XP; Huang ZY
    Sci Rep; 2021 Aug; 11(1):16343. PubMed ID: 34381132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant anti-PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy.
    Chen W; Hu S; Liu Z; Sun Y; Wu J; Shen S; Peng Z
    Hepatol Int; 2023 Apr; 17(2):406-416. PubMed ID: 36645648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of primary tumor location with long-term oncological prognosis following hepatectomy for hepatocellular carcinoma:A multicenter propensity score matching analysis.
    Tang SC; Lin KY; Huang TF; Zhang KL; Kong J; He XL; Luo C; Chen QJ; Guo PF; Zhou WP; Zeng YY
    Eur J Surg Oncol; 2023 Jul; 49(7):1234-1241. PubMed ID: 36774217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of combined α-fetoprotein and CA19-9 for hepatocellular carcinoma after hepatectomy.
    Zhang J; Qin SD; Li Y; Lu F; Gong WF; Zhong JH; Ma L; Zhao JF; Zhan GH; Li PZ; Song B; De Xiang B
    World J Surg Oncol; 2022 Oct; 20(1):346. PubMed ID: 36258212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of repeat hepatectomy for liver transplantable hepatocellular carcinoma recurrence after hepatectomy: a Retrospective Cohort Study with the Hiroshima Surgical Study Group of Clinical Oncology (HiSCO).
    Ohira M; Kobayashi T; Hamaoka M; Abe T; Onoe T; Inoue M; Honmyo N; Oishi K; Ohdan H;
    Langenbecks Arch Surg; 2023 Aug; 408(1):314. PubMed ID: 37584772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
    Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
    Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing trends in long-term outcomes after hepatic resection for hepatocellular carcinoma: A 30-year, single-center experience.
    Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    Anticancer Res; 2013 Nov; 33(11):5097-105. PubMed ID: 24222155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inflammation-based scores to predict prognosis of patients with hepatocellular carcinoma after hepatectomy.
    Huang J; Xu L; Luo Y; He F; Zhang Y; Chen M
    Med Oncol; 2014 Apr; 31(4):883. PubMed ID: 24535607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravoxel incoherent motion diffusion weighted imaging for preoperative evaluation of liver regeneration after hepatectomy in hepatocellular carcinoma.
    Li Q; Zhang T; Che F; Yao S; Gao F; Nie L; Tang H; Wei Y; Song B
    Eur Radiol; 2023 Aug; 33(8):5222-5235. PubMed ID: 36892648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes after hepatectomy of huge hepatocellular carcinoma: A single-center experience in China.
    Fang Q; Xie QS; Chen JM; Shan SL; Xie K; Geng XP; Liu FB
    Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):532-537. PubMed ID: 31543313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative low hepatitis C virus load predicts long-term outcomes after hepatectomy for hepatocellular carcinoma.
    Sasaki K; Shindoh J; Nishioka Y; Sugawara T; Margonis GA; Andreatos N; Pawlik TM; Hashimoto M
    J Surg Oncol; 2018 Apr; 117(5):902-911. PubMed ID: 29473962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of MR elastography for the preoperative estimation of liver regeneration capacity in patients with hepatocellular carcinoma.
    Jang S; Lee JM; Lee DH; Joo I; Yoon JH; Chang W; Han JK
    J Magn Reson Imaging; 2017 Jun; 45(6):1627-1636. PubMed ID: 27859840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal-invasive versus open hepatectomy for hepatocellular carcinoma: Comparison of postoperative outcomes and long-term survivals using propensity score matching analysis.
    Andreou A; Struecker B; Raschzok N; Krenzien F; Haber P; Wabitsch S; Waldbaur C; Touet EM; Eichelberg AC; Atanasov G; Biebl M; Bahra M; Öllinger R; Schmelzle M; Pratschke J
    Surg Oncol; 2018 Dec; 27(4):751-758. PubMed ID: 30449503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal duration of the early and late recurrence of hepatocellular carcinoma after hepatectomy.
    Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    World J Gastroenterol; 2015 Jan; 21(4):1207-15. PubMed ID: 25632194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlling nutritional status (CONUT) score-based nomogram to predict overall survival of patients with HBV-associated hepatocellular carcinoma after curative hepatectomy.
    Lin ZX; Ruan DY; Jia CC; Wang TT; Cheng JT; Huang HQ; Wu XY
    Clin Transl Oncol; 2020 Mar; 22(3):370-380. PubMed ID: 31201606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Background Liver Cirrhosis on Outcomes of Hepatectomy for Hepatocellular Carcinoma.
    Sasaki K; Shindoh J; Margonis GA; Nishioka Y; Andreatos N; Sekine A; Hashimoto M; Pawlik TM
    JAMA Surg; 2017 Mar; 152(3):e165059. PubMed ID: 28052155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.